These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 24507397)

  • 21. Understanding Interstitial Lung Disease: It's in the Mucus.
    Dickey BF; Whitsett JA
    Am J Respir Cell Mol Biol; 2017 Jul; 57(1):12-14. PubMed ID: 28665223
    [No Abstract]   [Full Text] [Related]  

  • 22. MUC5B Promoter Polymorphism and Survival in Indian Patients With Idiopathic Pulmonary Fibrosis.
    Dhooria S; Bal A; Sehgal IS; Prasad KT; Kashyap D; Sharma R; Muthu V; Agarwal R; Aggarwal AN
    Chest; 2022 Oct; 162(4):824-827. PubMed ID: 35405109
    [No Abstract]   [Full Text] [Related]  

  • 23. MUC5B: a good target for future therapy in pulmonary fibrosis?
    Mahida R; Turner AM
    Thorax; 2013 May; 68(5):401. PubMed ID: 23329274
    [No Abstract]   [Full Text] [Related]  

  • 24. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mucking around in the Genome: MUC5B in Idiopathic Pulmonary Fibrosis.
    Kolb M; White ES; Gauldie J
    Am J Respir Crit Care Med; 2016 Feb; 193(4):355-7. PubMed ID: 26871671
    [No Abstract]   [Full Text] [Related]  

  • 26. Personalizing Therapy in Idiopathic Pulmonary Fibrosis: A Glimpse of the Future?
    Kropski JA; Lawson WE; Blackwell TS
    Am J Respir Crit Care Med; 2015 Dec; 192(12):1409-11. PubMed ID: 26669470
    [No Abstract]   [Full Text] [Related]  

  • 27. Genetics and early detection in idiopathic pulmonary fibrosis.
    Putman RK; Rosas IO; Hunninghake GM
    Am J Respir Crit Care Med; 2014 Apr; 189(7):770-8. PubMed ID: 24547893
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Mathai SK; Humphries S; Kropski JA; Blackwell TS; Powers J; Walts AD; Markin C; Woodward J; Chung JH; Brown KK; Steele MP; Loyd JE; Schwarz MI; Fingerlin T; Yang IV; Lynch DA; Schwartz DA
    Thorax; 2019 Dec; 74(12):1131-1139. PubMed ID: 31558622
    [TBL] [Abstract][Full Text] [Related]  

  • 29. YKL-40 in pediatric asthma, MUC5B promoter polymorphism in idiopathic pulmonary fibrosis, and esmolol in septic shock.
    Kulkarni HS; Guzy RD; McEvoy C
    Am J Respir Crit Care Med; 2014 May; 189(9):1138-40. PubMed ID: 24787067
    [No Abstract]   [Full Text] [Related]  

  • 30. MUC5B Promoter Variant rs35705950 Affects MUC5B Expression in the Distal Airways in Idiopathic Pulmonary Fibrosis.
    Nakano Y; Yang IV; Walts AD; Watson AM; Helling BA; Fletcher AA; Lara AR; Schwarz MI; Evans CM; Schwartz DA
    Am J Respir Crit Care Med; 2016 Feb; 193(4):464-6. PubMed ID: 26871673
    [No Abstract]   [Full Text] [Related]  

  • 31. Synchronous cryptogenic liver cirrhosis and idiopathic pulmonary fibrosis: a clue to telomere involvement.
    Carulli L; Dei Cas A; Nascimbeni F
    Hepatology; 2012 Nov; 56(5):2001-3. PubMed ID: 23045155
    [No Abstract]   [Full Text] [Related]  

  • 32. [Serum biomarkers in idiopathic pulmonary fibrosis].
    Chudzicka A
    Pol Merkur Lekarski; 2010 Nov; 29(173):291-5. PubMed ID: 21268912
    [TBL] [Abstract][Full Text] [Related]  

  • 33. S100A9 in BALF is a candidate biomarker of idiopathic pulmonary fibrosis.
    Hara A; Sakamoto N; Ishimatsu Y; Kakugawa T; Nakashima S; Hara S; Adachi M; Fujita H; Mukae H; Kohno S
    Respir Med; 2012 Apr; 106(4):571-80. PubMed ID: 22209187
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Idiopathic interstitial pneumonia: classification and diagnostic work-up].
    Rochat T; Pache JC
    Rev Med Suisse; 2010 Nov; 6(272):2222-7. PubMed ID: 21207733
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pulmonary fibrosis, bone marrow failure, and telomerase mutation.
    Gansner JM; Rosas IO; Ebert BL
    N Engl J Med; 2012 Apr; 366(16):1551-3. PubMed ID: 22512499
    [No Abstract]   [Full Text] [Related]  

  • 36. Variability in
    Ghosh AJ; Moll M; Hobbs BD; Cardwell J; Saferali A; Castaldi PJ; Cho MH; Silverman EK; Yang IV; Hersh CP
    Am J Respir Crit Care Med; 2023 May; 207(10):1401-1404. PubMed ID: 36952240
    [No Abstract]   [Full Text] [Related]  

  • 37. Biomarkers in Interstitial lung diseases.
    Nathan N; Corvol H; Amselem S; Clement A
    Paediatr Respir Rev; 2015 Sep; 16(4):219-24. PubMed ID: 26027849
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Muc5b Enhances Murine Honeycomb-like Cyst Formation.
    Kurche JS; Dobrinskikh E; Hennessy CE; Huber J; Estrella A; Hancock LA; Schwarz MI; Okamoto T; Cool CD; Yang IV; Evans CM; Schwartz DA
    Am J Respir Cell Mol Biol; 2019 Oct; 61(4):544-546. PubMed ID: 31573335
    [No Abstract]   [Full Text] [Related]  

  • 39. Towards genetic reclassification of idiopathic pulmonary fibrosis.
    Wain L
    Lancet Respir Med; 2018 Aug; 6(8):569-570. PubMed ID: 29891357
    [No Abstract]   [Full Text] [Related]  

  • 40. Impact of Air Pollution and MUC5B Genotype on Survival in Idiopathic Pulmonary Fibrosis.
    Sesé L; Borie R; Kannengiesser C; Cottin V; Israel-Biet D; Crestani B; Cadranel J; Chenivesse C; Boubaya M; Valeyre D; Annesi-Maesano I; Nunes H;
    Ann Am Thorac Soc; 2024 Mar; 21(3):519-523. PubMed ID: 38096447
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.